Explore more
Leo Daily Horoscope Yahoo! Life Astrology
Digest more
In the wee hours of July 18th, Mercury, our planet of communication and exchange, lip service and slander, poetry and sexting, goes retrograde at 15° of Leo.
Pope Leo XIV celebrated Mass on July 15 in the chapel at the Carabinieri (a form of military police) station in Castel Gandolfo, Italy, where he is on vacation.
Pope Leo XIV made his first “getaway” from Castel Gandolfo to visit the Monastery of the Immaculate Conception of the Poor Clares of Albano.
The home in which Pope Leo XIV spent much of his childhood has been officially acquired by the village in which it is located.
At first glance it may not look like it, but the seeds of hope and faith are starting to grow in Dolton. There are signs that better days are just around the corner on 141st Place. WGN's Pat Elwood brings you the story.
E! News on MSN2d
Which Zodiac Signs Will Feel Mercury Retrograde in Leo the Most? Aliza Kelly Breaks It DownMercury Retrograde in Leo will rock our worlds from July 17 until August 11. As for which zodiac signs should brace for impact the most? Astrologer Aliza Kelly reveals what to expect to E! News.
Astrofame on MSN1h
Leo: Your career horoscope - July 16Your emotions could be intensified. You might feel a bit restless or frustrated. Try to manage those feelings in a practical way. Take frequent breaks so that you can clear your head. You might enjoy a long,
Remembering the anniversary of the proclamation of the Virgo Fidelis – Faithful Virgin – as the patroness of the Italian military police, Pope Leo XIV praised their dedication for helping those in “dangerous conditions.
The Barcelona native, 41, became the first woman to make the final table at the main event in 30 years and has a chance to be the first woman ever to win the tournament.
For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer Ingelheim 90 million euros ($105 million) up front for the rare disease drug Spevigo.
LEO Pharma A/S agreed to acquire the global rights for skin disease drug Spevigo from Boehringer Ingelheim GmbH, as the Danish dermatology specialist strengthens its portfolio ahead of a planned initial public offering in 2026.
Feedback